Clinical Trials Logo

Clinical Trial Summary

This clinical trial aims to assess the effect of providing one avocado per day on skin health in comparison with a control group maintaining their habitual diets. Participants will be randomly assigned to one of two equally sized groups. Both groups will be instructed to continue to follow their habitual diet but the intervention group will receive one avocado per day. Participants will be followed for outcomes for a four-month period.


Clinical Trial Description

This study will be a randomized, parallel group comparison of daily avocado consumption vs. habitual diet. The study will be carried out in accordance with the guidelines of the Human Subjects Protection Committee of the University of California, Los Angeles. All subjects will give written informed consent before the study begins. At screening, informed consent and HIPAA authorization will be reviewed and signed. A medical history will be obtained. Enrollment will be reviewed by the study physician according to inclusion and exclusion criteria. Skin type and response to UVB will be assessed. At baseline, participants will undergo skin testing. Subjects will consume 1 avocado a day (Hass Avocado) or maintain habitual diet (up to 2 avocados/month) daily for 16 weeks. Skin will be assessed at weeks 0, 8 and 16. Each group will have 20 subjects as calculated by power analysis. Two additional subjects for each group will be recruited for possible dropouts and a total of 22 subjects will be recruited for each group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05102604
Study type Interventional
Source University of California, Los Angeles
Contact
Status Completed
Phase N/A
Start date January 1, 2020
Completion date December 30, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04479514 - Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy Phase 2
Completed NCT03065504 - Turmeric and Turmeric-containing Tablets and Sebum Production N/A
Recruiting NCT05535738 - Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation Phase 2/Phase 3
Recruiting NCT05277324 - The Effect of Wearing Facial Masks on Skin Parameters During the COVID-19 Pandemic
Completed NCT05300542 - Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema N/A
Completed NCT05745636 - Broccoli Seed Extract and Skin Health N/A
Completed NCT03192280 - Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response N/A
Withdrawn NCT03976206 - Very Small Embryonic-like Stem Cells for Facial Skin Antiaging Phase 1/Phase 2
Withdrawn NCT03862872 - Effects of Bend Beauty's Anti-Aging Formula on Inflammatory Markers N/A
Completed NCT04471896 - Joovvin' for Your Skin Health Study N/A
Recruiting NCT03581747 - Detection of Skin Epithelial Barrier in Patients With Allergic Skin Disorders
Recruiting NCT06387212 - 35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of Skin N/A
Completed NCT05517720 - An Exploratory Investigation of a Novel Skincare Regimen N/A
Completed NCT05461456 - Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% Phase 1